Dartmouth researchers were awarded nearly $11 million during March, including $4.3 million in new and competing awards. Among the recipients of recent new and competing grants, as reported by the Office of Sponsored Projects:
National Investor Relations Institute
"Strategic Corporate Communication Research"
Alexander S Onassis Public Benefit Foundation
"Coming of Age in Ancient Greece: Images of Childhood"
National Heart, Lung, and Blood Institute
"Structure-Function Analysis of ACAT"
4-Year Award
Dept of Defense, U.S. Army Medical Research and Materiel Command
"Micro RNA's in Normal and Malignant Human Breast Cells"
2-Year Award
National Institute of Child Health and Human Development
"Uterine and Postnatal Maternal Environment Interactions"
2-Year Award
Health Resources and Services Administration
"Emergency Medical Services for Children"
3-Year Award
Riverside Research Institute
"The Software Protection Initiative"
Averion Incorporated
"Study of Progression-Free Survival in ChemoFX Assay Sensitive or Resistant Subjects with Stage III-IV Ovarian Cancer"
Varian Medical Systems, Incorporated
"RPM Respiratory Gating System"
Connecticut Dept of Mental Health and Addiction Services
"Integrated Dual Disorders Treatment Implementation"
and
Eli Lilly and Company
"EBP Text Project"
National Institutes of Health
"Critical Glucocorticoid/Cytokine Mechanisms in Endotoxemia"
5-Year Award
American Heart Association
"Structural and Biophysical Characterization of Conventional and Unconventional Myosins"
4-Year Award
Wyeth Pharmaceuticals Incorporated
"Phase I Dose Escalation Study of MAC-321"
Connecticut Dept of Mental Health and Addiction Services
"Treatment of Psychiatric Comorbidity in SAT Programs: Phase II"
Veterans Administration
"VA/Post Traumatic Stress Disorder‚"
3-Year Award
National Institutes of Health
"Mechanisms of PAI-1 Induced Anti-Angiogenesis"
4-Year Award
National Institutes of Health
"Mechanisms of Biofilm Antibiotic Resistance"
5-Year Award
and
National Institute of Allergy and Infectious Diseases
"Mechanisms of Biofilm Antibiotic Resistance in Staphylococcus"
2-Year Award
Dept of Defense, U.S. Army Medical Research and Materiel Command
"Exploratory Studies of Magnetic Resonance Microwave Absorption Imaging for the Breast"
2-Year Award
AstraZeneca Pharmaceuticals LP
"Phase II Trial with Iressa and Tamoxiifen-Resistant Metastatic Breast Cancer"
Cystic Fibrosis Foundation
"P. aeruginosa Pathogenicity and Airway Epithelial Cell Function"
3-Year Award
Department of Justice, National Institute of Justice
"Combating Terrorism: Second Year Budget Proposal and Statement of Work"
BC International Corporation
"Integration of an Advanced Cellulase-Producing Ethanologenic Bacteria with Pretreatment to Significantly Reduce the Cost of Ethanol from Biomass"
Award commitment from the sponsoring agency is for a single year unless otherwise indicated.
